Join the "Post-merger integrations in life sciences. The good, the bad, the ugly" in-person panel discussion on July 27, 10-11 am to learn from buyers, and entrepreneurs what to look out for and what mistakes to avoid during mergers and acquisitions before and after the transaction.
The founders of DxPx are all startup entrepreneurs and former industry executives who had the idea for this conference after having attended numerous partnering events where the vast majority of participants and investors were focused on pharma, biotech, and drug screening opportunities.
With the gaining importance of diagnostics, digital health, precision medicine, and life science tools, there‘s a need for a dedicated platform to bring together the relevant stakeholders and further drive our industries.
Together with the support of our sponsors DxPx is hosted as an annual international partnering conference to facilitate licensing, financing, co-development, and M&A opportunities and celebrates great success and fast growth.
We look forward to welcoming you in person at the DxPx US!